554 related articles for article (PubMed ID: 26387063)
1. Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Talbot JJ; Kidd SE; Martin P; Beatty JA; Barrs VR
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():37-41. PubMed ID: 26387063
[TBL] [Abstract][Full Text] [Related]
2. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Arendrup MC; Jensen RH; Cuenca-Estrella M
Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
[TBL] [Abstract][Full Text] [Related]
5. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
[TBL] [Abstract][Full Text] [Related]
6. Azole preexposure affects the Aspergillus fumigatus population in patients.
Alanio A; Cabaret O; Sitterlé E; Costa JM; Brisse S; Cordonnier C; Bretagne S
Antimicrob Agents Chemother; 2012 Sep; 56(9):4948-50. PubMed ID: 22710122
[TBL] [Abstract][Full Text] [Related]
7. Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.
Buil JB; van der Lee HAL; Rijs AJMM; Zoll J; Hovestadt JAMF; Melchers WJG; Verweij PE
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923874
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
11. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
[TBL] [Abstract][Full Text] [Related]
14. Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Kidd SE; Goeman E; Meis JF; Slavin MA; Verweij PE
Mycoses; 2015 Jun; 58(6):350-5. PubMed ID: 25885568
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Nabili M; Shokohi T; Moazeni M; Khodavaisy S; Aliyali M; Badiee P; Zarrinfar H; Hagen F; Badali H
J Med Microbiol; 2016 Jun; 65(6):468-475. PubMed ID: 27008655
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Meletiadis J; Mavridou E; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2012 May; 56(5):2524-9. PubMed ID: 22330922
[TBL] [Abstract][Full Text] [Related]
17. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
[TBL] [Abstract][Full Text] [Related]
18. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
[TBL] [Abstract][Full Text] [Related]
19.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
